What is the standard pediatric regimen in the initial phase?

• A. Often RIPE with weight-based dosing; adjusted for weight in children, similar four-drug initial phase
• B. Isoniazid monotherapy in children
• C. Rifampin monotherapy in children
• D. Pyrazinamide alone in children

Answer: (A)

The main idea is that treating a child with drug-susceptible TB starts with a four-drug, multi-agent regimen given by weight-based dosing to rapidly reduce the bacterial load and prevent resistance. In pediatrics, the standard initial phase uses rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE) for about two months, with doses adjusted to the child’s weight. This combination provides broad coverage, leverages the synergistic activity of the drugs, and helps shorten the overall course of therapy while reducing the risk that the organism becomes resistant to a single drug. Monotherapy with one drug, such as isoniazid alone, rifampin alone, or pyrazinamide alone, would be insufficient and prone to resistance and treatment failure, which is why the four-drug initial phase is the preferred standard in children.